[Treatment of venous thromboembolic disease using low molecular weight CY216 heparin in patients with high risk of hemorrhage].
Prandoni
P
P
Vigo
M
M
Tropeano
P F
PF
Carletti
E
E
Corbetti
F
F
Antonello
G
G
Cuppini
S
S
D000328:Adult; D000368:Aged; D004334:Drug Administration Schedule; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control*; D006493:Heparin / Q000009:adverse effects; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy*; D012307:Risk Factors; D013924:Thrombophlebitis / Q000188:drug therapy*
D006495:Heparin, Low-Molecular-Weight; D006493:Heparin
Terapia della malattia tromboembolica venosa con eparina a basso peso molecolare CY216 in pazienti ad alto rischio di emorragia.